Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 3, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$167B
sum of reported positions
Reported positions
567
Changes vs prior quarter
589
80 new · 75 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 178 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $145B | $167B |
| Positions | 562 | 567 |
| Biggest line | — | NVIDIA 8% |
| 21.4M |
| $8.09B |
| 4.8% |
| 18.8M | $6.72B | 4.0% |
| 5.46M | $6.55B | 3.9% |
| 16.3M | $6.09B | 3.7% |
| 9.97M | $5.79B | 3.5% |
| 10.7M | $5.1B | 3.1% |
| 14M | $4.95B | 3.0% |
| 7.37M | $4.15B | 2.5% |
| 10.9M | $4.08B | 2.4% |
| 8.57M | $3.6B | 2.2% |
| 3.76M | $2.87B | 1.7% |
| 5M | $2.57B | 1.5% |
| 6.93M | $2.38B | 1.4% |
| 18.5M | $2.1B | 1.3% |
| 9.52M | $2.06B | 1.2% |
| 2.17M | $2.03B | 1.2% |
| 27.1M | $1.93B | 1.2% |
| 6.86M | $1.79B | 1.1% |
| 4.5M | $1.69B | 1.0% |
| 9.22M | $1.63B | 1.0% |
| 6.34M | $1.61B | 1.0% |
| 3.53M | $1.53B | 0.9% |
Boston Scientific (BSX)
898K shares in Q1 2026
Lifezone Metals (LZM)
790K shares in Q1 2026
Riskified (RSKD)
703K shares in Q1 2026
GE HealthCare (GEHC)
695K shares in Q1 2026
First Interstate BancSystem, Inc. (FIBK)
587K shares in Q1 2026
Black Rock Coffee Bar (BRCB)
584K shares in Q1 2026
Waystar Holding Corp (WAY)
516K shares in Q1 2026
TERNS PHARMACEUTICALS INC
501K shares in Q1 2026
Avalo Therapeutics (AVTX)
471K shares in Q1 2026
Roblox (RBLX)
438K shares in Q1 2026
Alto Neuroscience (ANRO)
386K shares in Q1 2026
Estée Lauder Companies (The) (EL)
375K shares in Q1 2026
Xylem Inc. (XYL)
276K shares in Q1 2026
Duke Energy (DUK)
255K shares in Q1 2026
Pacific Biosciences of California (PACB)
230K shares in Q1 2026
Futu Holdings (FUTU)
212K shares in Q1 2026
Janus Living (JAN)
200K shares in Q1 2026
Abbott Laboratories (ABT)
190K shares in Q1 2026
Lindsay Corporation (LNN)
184K shares in Q1 2026
Orchid Island Capital (ORC)
169K shares in Q1 2026
Universal Display (OLED)
141K shares in Q1 2026
Hillman Solutions (HLMN)
126K shares in Q1 2026
Ellington Financial, Inc. (EFC)
121K shares in Q1 2026
Bio-Techne (TECH)
119K shares in Q1 2026
Regeneron Pharmaceuticals (REGN)
115K shares in Q1 2026